NFKB1 and breast cancer: The constitutive or aberrant activation of NF-κB is also often found in a variety of solid tumors including ovarian cancer [6], prostate cancer [7], gastric carcinoma [8], colorectal cancer [9], hepatocellular carcinoma, [10] breast cancer [11], and triple negative breast cancer [12].